NL-OMON40745RecruitingNot Applicable
Influence of BCG vaccine as a booster for TDaP-IPV vaccination - Influence of BCG
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Sponsor
- Radboudumc
- Enrollment
- 51
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 to 99 (—)
Inclusion Criteria
- •Healthy adults
Exclusion Criteria
- •Systemic medication other oral contraceptives. Diseases resulting in immunodeficiency. Previous BCG vaccination. Pregnancy.
Investigators
Similar Trials
Unknown
Phase 4
Influence of BCG on TDaP-IPV VaccinationWhooping CoughNCT02771782Radboud University Medical Center75
Completed
Not Applicable
Immunological effects of BCG on vaccination with the yellow fever vaccine.Immune modulationmodulation of the immune system10002252NL-OMON40902niversitair Medisch Centrum Sint Radboud30
Recruiting
Not Applicable
The effect of BCG vaccination in treatment of patients with type 1 diabetes mellitusIRCT2017042919940N2Vice chancellor for research, Shiraz University of Medical Sciences52
Active, not recruiting
Not Applicable
DTaP-IPV-Hib, with or without Hep B, booster vaccination in subjects aged 11 to 18 months previously vaccinated with a DTaP-IPV-Hib combination vaccine, with or without Hep B.EUCTR2012-001042-18-ESSanofi Pasteur SA795
Active, not recruiting
Not Applicable
Effect of BCG vaccination for tuberculosis on COVID-19 in BrazilCOVID-19 (SARS-CoV-2 infection) in persons who were previously given the BCG vaccineInfections and InfestationsISRCTN47802196ational Council for Scientific and Technological Development200,805